Further research is needed to determine which regions are necessary for the formation of this circ-LRIG3/EZH2/STAT3 ternary complex, so as to design small interfering peptides to block their binding, which may be a promising new approach for the treatment of HCC. This evidence concerns the gene STAT3 and hepatocellular carcinoma.